Vectors expressing adenovirus 5 E1A or a domain 2 mutant E1A were introduced into CHO-K1 cells in order to transactivate the hCMV-MIE promoter in transient and stable transfections. Expression from the hCMV promoter was efficiently activated by both wild-type and mutant E1A in contrast to other viral promoters such as the SV40 early promoter which are repressed by E1 A. E1A genes expressed from a strong promoter were inhibitory to the growth of CHO cells. Nevertheless, by the use of a weaker promoter, it was possible to Isolate stably transfected cell lines containing a level of E1A compatible with both continued cell growth and significant transactlvation of the hCMV promoter. By this means we have generated cell lines secreting tissue Inhibitor of metalloproteinases (TIMP) at levels approaching those previously attained using gene amplification. CHO cell lines constitutively expressing wild-type and mutant E1A genes have been derived which can serve as new host cell lines for transient expression and efficient stable expression without gene amplification.
INTRODUCTION
Selection for vector amplification has commonly been used to achieve high level gene expression in mammalian cells (1) (2) (3) . However selection for gene amplification is time consuming and can lead to cell lines which are unstable if selection pressure is removed (4) .
A low copy number expression system that is capable of generating as much product as current gene amplification systems would be preferable because highly expressing recombinant cell lines could be generated rapidly and may be more stable than gene-amplified lines in the absence of continued selection. One possible approach to improving the efficiency of low copynumber expression vectors is to co-express a gene capable of stimulating transcription from the expression vector. The adenovirus El A gene has been used to transactivate a number of viral promoters in transient expression experiments (reviewed by Flint and Shenk (5) ). Human 293 cells and adenovirus 12 transfected hamster cells, both of which contain adenovirus early proteins including El A and E1B, have also been used for efficient stable expression of recombinant proteins (6, 7) . In order to derive a more versatile transactivation system, not restricted to adenovirus transformed cell lines, we have set out to test whether El A in the absence of other adenoviral early proteins could transactivate heterologous genes efficiently in other cell types. In particular we wished to test the potential of an El A expression system in a CHO cell line, in which gene amplification has been widely used, so that a direct comparison of the two systems could be made.
The hCMV-MIE promoter is highly efficient in CHO cells (2, 8) . It contains TATAA and cyclic-AMP response elements (9,10) which have been proposed to mediate transactivation by adenovirus E1A gene products (5) . Indeed, El A has recently been demonstrated to activate the hCMV-MIE promoter in transient expression experiments in primate cells (11) . This therefore seemed an appropriate promoter for exploring the potential of El A transactivation in CHO cells, particularly since we had also studied the hCMV promoter in gene amplification systems (2) .
The El A gene encodes 2 major gene products, one a 289 amino acid nuclear phosphoprotein involved in transactivation and the other a 243 amino acid protein translated in the same reading frame as the 289 protein. The mRNAs for the 289 and 243 amino acid proteins are generated by alternative RNA splicing of a common El A mRNA precursor (5). The two polypeptides are identical in amino acid sequence, except for an internal 46 amino acid region unique to the 289 protein and constituting the majority of the 49 amino acid domain 3, which has been shown to be necessary for transactivation (12) . A 49 amino acid peptide corresponding to this region has also been shown to be sufficient for transactivation when micro injected into the nucleus of cells (13) . Domains 1 and 2, common to each protein, are involved in oncogenic transformation (12) . El A can also repress a number of enhancer elements (14, 15) and cellular genes (16) . The repression of the cellular genes stromelysin, c-myc and JE requires only the functions of domain 1 (16) whereas repression of the SV40 and Polyomavirus enhancers requires domain 2 (14) . Since it is not clear whether an hCMV promoter-enhancer will be subject to the repression function of El A we chose to compare the activities of wild-type E1A and a point mutation described previously (14) which inactivates the repression and transformation functions of domain 2. This paper describes the introduction of wild type and mutant El A genes into CHO-K1 cells both transiently and to derive permanent cell lines. By this means a CHO-K1 derivative has been established that permits expression of recombinant genes from the hCMV-MIE promoter in initial transfectants at levels comparable to those previously attainable in CHO cells using gene amplification.
MATERIALS AND METHODS

Vector Construction
The vector pIA (17) comprises base pairs 1 to 1834 of adenovirus type 5 DNA cloned into the bacterial vector pML between its Eco RI and Bam HI sites. This segment of adenovirus DNA contains the E1A gene, including its polyadenylation signal and promoter. To inactivate domain 2, amino acid 126 (5) was converted from a glutamate to a glycine by site directed mutagenesis in M13 (18) using an oligonucleotide of the sequence 5'ACCTGCCACGGGGCTGGCTTT 3'. This mutated gene is referred to as mElA.
In order to replace the natural El A promoter upstream of the El A and mElA genes with alternative viral promoters, the El A promoter was removed and a unique Hind HI site was inserted upstream of each gene as follows. A 4kb Eco RI, partial Bst XI fragment from the pi A and pmElA vectors was isolated. Each fragment was ligated separately with 2 oligonucleotides of the following sequence: 5' AATTCAAGCTTCCACCATGAGACATATTATCTGGC-ACGGAGGTGTTATTACCGAAGAAATGGCCGCCAGT-CTT 3' and 5'CTGGCCGCCATTTCTTCGGTAATAACAC-CTCCGTGGAGATAATATGTCTCATGGTGGAAGCTTG 3' This creates the promoterless plAAP and pmElAAP vectors with unique Hind HI and Eco RI directly 5' to the El A genes.
The hCMV-MIE promoter as a 2.1kb Hind HI fragment (19) and the SV40 early and late promoters as a 350 bp Hind HI origin fragment (2) were inserted into the unique Hind III site of pi AAP and pmEl AAP vectors to create the series of vectors shown in Figure 1 . A bacterial xanthine-guanine phosphoribosyl transferase (gpt) gene under control of the SV40 early promoter from pSV2GPT (20) was inserted as a Pvu II to Bam HI fragment with addition of Sal I linkers at the unique Sal I site downstream of the El A genes in each of the vectors shown in Figure 1 , giving GPT derivatives of each suitable for transfection and selection in CHO cells. The vector pEE6.gpt has the same Pvu II to Bam HI fragment from pSV2.gpt, Bam HI linkered into the Bam HI site of pEE6 (21) .
pEE7Salne was constructed by isolating the BamHI fragment from pSV3Bne (22) which contains a G418 resistance gene under the control of a SV40 early promoter, addition of Sal I linkers and insertion into the Sal I site of pEE7 (21) .
The vector pHTIMP2 has been previously described (2) . pHCollGS was constructed as follows: A Hind HI site was introduced 47bp upstream of the translation initiation site in the human procollagenase cDNA (23) by standard techniques. The Hind IH to Bgl II fragment containing the complete coding sequence was inserted into pEE6hCMV (21) between the Hind HI and Bel I sites, such that the hCMV promoter will transcribe the procollagenase cDNA, creating the vector pHColl. A Bam HI glutamine synthetase (GS)-minigene fragment from pHTIMP2.GS (2) was then inserted into the Bam HI site downstream of the procollagenase cDNA in pHColl to produce pHCollGS.
Cell Culture and Transfection Protocols CHO-K1 cells (ATCC : CCL61) and 293 cells (24) ( obtained from the Sir William Dunn School of Pathology, Oxford) were cultured in DMEM containing 10% foetal bovine serum, nonessential amino acids, glutamine and antibiotics penicillin and streptomycin (GIBCO). CHO cells transfected with vectors containing a gpt selectable marker were cultured in this growth medium containing Hypoxanthine and Thymidine (GIBCO), xanthine (0.25mg/ml) and mycophenolic acid (10/ig/ml). Cells transfected with vectors containing a neo gene were cultured in the same growth medium containing G418 (lmg/ml). CHO cells transfected with vectors containing the GS selectable amplifiable marker were cultured in GMEM-S medium (25) with methionine sulphoximine (MSX) added to 20/tM.
Stable cell-line transfections were carried out by seeding 1 -2 x 10 6 cells in a 9cm petri dish. Following up to 24 hours incubation in growth medium, each petri dish was transfected with 10/tg vector DNA by calcium phosphate co-precipitation followed by glycerol shock (26) . Following a further 24 hours incubation in growth medium, appropriate selection was added. All cultures were fed weekly with fresh selective medium. After 14-21 days resistant colonies were picked and grown in mass culture.
Transient transfections for comparison of El A transfectant celllines were performed essentially as for stable cell-lines except that only 3/tg of vector was used. Samples of culture medium for assay were taken 24 to 72 hours post transfection. For transient co-transfections of pH.TTMP2 and E1A vectors, 4^g of each DNA was used per petri dish and transfections were carried out as above.
Analysis of RNA
RNA purification, Northern blot and slot-blot analysis were performed according to standard techniques (18) . The Hind HI to Bam HI TTMP cDNA fragment (27) , a 700bp Bam HI to Pst I a actin cDNA fragment (28), a Pst I rat glyceraldehyde phosphate dehydrogenase (GAPDH) cDNA (29) and a 700bp Eco RI to Xba I E1A gene fragment from plAAP were inserted into the riboprobes pSP64 and pSP65 (Promega). These were used to prepare 32 P-labelled RNA probes essentially as described by Melton et.al., (30) .
TEMP and Procollagenase ELISAs
Culture supematants were assayed for TIMP and procollagenase using ELISAs already described (2, 31) .
RESULTS
Construction of E1A expression vectors
A number of El A expression plasmids were constructed to test the effect of the adenovirus E1A protein, and a mutant which is defective for the repression and transformation functions, on the hCMV-MIE promoter-enhancer. Two different El A coding regions were used, the wild type E1A gene from pIA (17) and a point mutation that converts Glu 126 into a Gly (14) . This gene is called mElA. Since it is not known what level of E1A expression will be optimal for transactivation, each gene was expressed from three promoters known to be of different strengths in CHO cells, i.e. the hCMV-MIE, SV40 early and SV40 late promoters, to derive the expression vectors shown in Figure 1 . For some experiments, E1A genes were expressed from the E1A promoter, although the strength of this in CHO cells is unknown. 
Transient Transactivation of the hCMV Promoter by ElA
The test plasmid used to assay the effect of ElA on expression from the hCMV promoter is pHTIMP2 (2) containing the hCMV-MIE promoter-enhancer and complete 5' untranslated sequence directly upstream of a cDNA encoding tissue inhibitor of metalloproteinases (TIMP). TIMP was chosen as the reporter gene as the product is secreted and is readily assayable from culture medium using an ELISA (2). pHTIMP2 was co-transfected into CHO-K1 cells with each of the ElA expression vectors shown in Figure 1 . The results shown in Table 1 indicate that co-transfection of a wild type ElA gene under the control of the hCMV-MIE promoter leads to a 2-3 fold increase in transient TIMP production. This is consistent with the results of Gorman et al., (11) , who demonstrated in primate cell lines that an hCMV promoter linked to a chloramphenicol acetyl transferase (CAT) reporter gene produces about two fold more CAT activity in the presence of El A. The mElA protein also yields a 2-3 fold increase in TIMP productivity (Table 1) . For both ElA proteins expression from the SV40 early promoter gave reduced levels of transactivation and expression from the SV40 late promoter did not yield detectable activation. We have found previously in transient expression experiments that the order of promoter strength in CHO-K1 cells is hCMV-MIE > SV40 early > SV40 late (2) .This order of promoter strength correlates with the degree of transactivation by the ElA expression vectors, implying that more ElA expression leads to greater transactivation of the hCMV-MIE promoter (assuming that the relative promoter strengths are not themselves affected by the presence of ElA). In contrast, a TTMP gene expressed from the SV40 early promoter is repressed by co-transfection with pi A and not by pmElA (14 and M.I.C. unpublished). This suggests that the hCMV-MIE promoter-enhancer is not sensitive to the repression function of domain 2 of ElA in CHO cells.
Permanent Expression of ElA in CHO Cell Lines
Preliminary attempts to introduce the wild type and mutant ElA genes into CHO-K1 cells resulted in very low transfection efficiencies, suggesting that these proteins may interfere with continued cell growth. In order to test thts, one of the ElA expression vectors, pHmElA, was co-transfected with the plasmid pEE7Salne which contains a G418 resistance gene. Increasing concentrations of the mElA expression vector reduced the transfection efficiency of the co-transfected G418 resistance vector, indicating that expression of mElA can indeed inhibit cell growth (data not shown). A control mElA vector without a promoter had no significant effect on colony formation.
In order to achieve El A expression at a level compatible with both transactivation and cell growth, the El A genes expressed from promoters of different strengths were tested. A selectable marker for mammalian cells, the xanthine-guanine phosphoribosyl transferase (gpt) gene from pSV2.gpt (20) , was placed downstream of the El A genes. These vectors were then transfected into a CHO-K1 derivative, GS19.12, containing a single intact copy of the TIMP cDNA under control of the hCMV-MIE promoter/enhancer region (2). GS19.12 secretes 9/ig TTMP/10 6 cells/24h.
The number of colonies obtained after transfection with mEl A gene vectors (shown in Table 2 ) decreases with increase in the strength of the promoter expressing El A again indicating the toxicity of high level expression of this protein. The TIMP specific production rates of pooled MPA-resistant colonies from each transfection (see Table 2 ) are 2-5 fold higher when the El A genes are under control of the weaker SV40 early or late promoters or the E1A promoter. Thus, low levels of E1A expression are still compatible with significant transactivation.
The three GS19.12 E1A transfectant pools having the highest TIMP production rates were cloned by limiting dilution and the productivity of a number of clones from each pool is shown in Table 3 . Two of these clones secrete at least 8 fold more TIMP than GS19.12. Such levels of expression approach the highest levels of TIMP expression achievable after selection for vector amplification in this cell-line (HO/tg/K^cells^h) (2) .
In order to confirm that the increased TIMP productivity was due to transactivation of the hCMV-MIE promoter, steady state levels of TIMP mRNA were analysed. Northern blot analysis was carried out using cytoplasmic RNA from GS19.12 and the two highest producing cell lines EE1A.4 and LmElA.32 (see figure 2 ). TTMP mRNA in the two El A containing cell lines increased by about 3 fold in each case, as estimated by scanning the autoradiograph and by slot-blot hybridisation, relative to G-APDH mRNA used as an internal standard. However the increase in TTMP mRNA is not sufficient to account completely for the ten fold increase in TIMP productivity, indicating that factors in addition to transcriptional activation may be involved in increasing the productivity per cell. To investigate the stability of an mElA activated cell line, LmElA-32 was cultured in glutamine-free medium in the absence of MSX for over 35 cell generations. The TIMP productivity after this time was 62 /tg/10 6 cells/24h ie, the cell line is essentially stable over this period. In contrast the gene-amplified cell line secreting the highest level of TIMP requires MSX to maintain stability (2).
Isolation of E1A Transfectant CHO-K1 Cells
For rapid isolation of highly productive recombinant cell-lines it would be more efficient to introduce recombinant expression vectors into a cell-line already expressing the transactivator. The two E1A expression vectors yielding the most efficient transactivation in the GS19.12 cell-line, pEElA.gpt and pLmElA.gpt, were therefore transfected separately into CHOKl cells by calcium phosphate co-precipitation. 12 MPA resistant colonies were isolated from each transfection and screened for Table 4 were cloned out and TIMP production rates were measured for a number of sub-clones from pEElA, pmElA and pLmElA transfectants respectively. Results are means of at least two independent assays. their ability to secrete TIMP transiently when transfected with the vector pHTIMP2 (see Table 4 ). Two cell lines showed significantly increased TIMP productivity. One cell line, CHO-L761 (containing pLmElA.gpt), transiently expressed TIMP approximately ten fold more efficiently than CHO-K1 cells. This cell line was re-cloned by limiting dilution to obtain a sub-clone CHO-1761h.
Northern Analysis of niElA Transfectants
In order to confirm that the increased recombinant gene expression obtained in CHO-L761h cells correlates with mElA gene expression, poly A+ mRNA was prepared from the cell lines CHO-L761h, LmElA.32 and the parent lines of each of these prior to transfection of the pLmElA expression plasmid. The adenovirus-transformed human 293 cell line was used as a positive control for E1A expression. A Northern blot of these mRNAs was probed sequentially with El A and actin probes and the results are shown in Figure 3 . It can be seen that both of (as a control for loading) from cell lines. (1). 293, (2). CHO-L761h, (3).  GS 19.12, and (4). GS 19.12LmElA-32. the mElA transfectants independently isolated for their ability to secrete high levels of recombinant product, contain similar quantities of mElA mRNA which is considerably less than the level in 293 cells. Other mElA transfectants which did not express TIMP as efficiently as either CHO-L761h or LmElA.32 contained mElA mRNA at lower levels (data not shown).
Comparison of CHO-K1 and CHO-L761h as Host CeO-Lines for Permanent Transfection
In order to confirm that the effect of El A is not restricted to the expression of TIMP, CHO-K1 and CHO-L761h cell-lines were transfected with a human procollagenase expression vector to compare the efficiency of recombinant protein production in permanently transfected cell-lines. pH.CollGS contains a human procollagenase cDNA (23) under the control of the hCMV-MIE promoter and the GS minigene from pSVLGS. 1 as the selectable marker (25) . After transfecting this vector into both CHO-K1 and CHO-L761h cell-lines, 24 colonies resistant to 20 /xM MSX were isolated from each transfection and assayed for their ability to secrete human procollagenase using an ELJSA. Procollagenase production rates are shown for the 6 highest secreting cell lines from each transfection in Table 5 . It is clear that all of the CHOL761h transfectants analysed secrete more procollagenase than the CHO-K1 transfectants. The best CHO-K1 cell-lines secreted no more than l/tg/10 6 cells/24h whereas the best CHO-L761h transfectant secreted 13/tg/lO 6 cells/24h, indicating that the CHO-L761h cell line is indeed capable of more efficient expression of recombinant proteins than CHO-K1 cells.
DISCUSSION
The introduction of El A genes into CHO-K1 cells has led to a number of interesting findings concerning the effects of El A on the hCMV promoter and on the physiology of CHO cells. The wild-type El A gene is known to act both as a transcriptional activator of a number of promoters and as a repressor of a variety of viral enhancers and cellular genes. We therefore used transient expression assays to compare the ability of El A and a mutant El A gene defective for viral enhancer repression (14) , to transactivate the hCMV-MIE promoter-enhancer in CHO-K1 cells. Both genes increased expression of TIMP from the hCMV-MIE promoter-enhancer to equivalent levels, suggesting that the hCMV enhancer is in fact unusual among viral enhancers in that it is not substantially repressed by El A. This is consistent with results obtained by Gorman er.a/.,(ll) who showed that E1A-mediated activation of the hCMV TATA-box region was only marginally reduced by the presence of the hCMV enhancer. We also found that stronger promoters, used to express El A in transient expression experiments yielded more efficient transactivation, consistent with the suggestion that El A transactivation is concentration dependent (32) .
Although transient expression indicated that higher levels of El A led to more efficient transactivation of the hCMV promoter, selection for permanent expression of El A or mElA indicated that the products of these genes have other effects on the physiology of CHO cells. Expression of El A genes from an efficient promoter led to low transfection efficiencies, indicating that they are inhibitory to the growth of CHO-K1 cells, perhaps because of the influence of El A on the expression of one or more cellular genes involved in cell proliferation. One candidate would be the c-myc gene which is repressed by El A proteins containing domain 1 (16) , present in all the vectors used here. Alternatively other cellular genes whose over-expression is inhibitory to cell proliferation may be activated by domain 3.
Nevertheless, it was possible to identify stable transfectants expressing low levels of either E1A or mElA which showed significant transactivation of a chromosomally integrated hCMV-TTMP expression vector. Increases in TTMP productivity of upto 10 fold were observed, although the TEMP mRNA levels only increased 3 fold. It is likely that the effects of El A on other cellular functions are responsible for the additional increase.
Despite the fact that the functions of El A are not completely understood, it is clear that CHO-K1 cells expressing El A genes permit very efficient expression from the hCMV promoter. Cell lines containing a single intact copy of the TTMP expression vector and an E1A or mElA gene secrete TIMP at levels approaching those previously obtainable using gene amplification (2) . Introduction of E1A vectors into a GS amplified cell line secreting TIMP did not yield a substantial increase in productivity (data not shown) and further rounds of selection for gene amplification did not lead to higher-producing cell lines (2). Thus both gene amplification and El A transactivation can ultimately achieve similar productivities. The introduction of E1A expression plasmids has the advantage over gene amplification systems that cell lines containing low vector copy numbers may be more stable in the absence of continued selective pressure because of the probability in gene amplified cell lines of loss of gene copies by homologous recombination in large tandem arrays. Indeed, the LmElA.32 cell line is stable for more than 35 generations without MSX, whereas a GS-amplified cell line derived from GS19.12 is not (2) .
For rapid identification of highly-expressing recombinant cell lines using ElA-mediated transactivation, it is preferable to use a modified host cell line already expressing the appropriate level of the activator. Either the El A or mElA genes expressed from relatively weak promoters could be used to establish such a cell line. An example is the cell line CHO-L761h, which contains the mElA gene expressed from the SV40 late promoter. This cell line expresses mElA mRNA at a level approximately 1/5 of the El A mRNA level in 293 cells. Interestingly the level of mRNA is very similar to that in a cell line derived by transfecting the mEl A gene into a TIMP vector containing cell line (GS19.12) and subsequent screening for efficient transactivation. Since transactivation appears to be concentration dependent and both E1A and mElA are inhibitory to cell growth at high concentrations, it is likely that the level of mEl A in these cell lines is essentially optimal for the transactivation of the hCMV promoter in CHO cells.
The El A expression vectors described here may also be useful for obtaining efficient transactivation in other cell types. However the appropriate level of El A and the frequency at which cell lines expressing this level can be derived is likely to depend on the cell type and the vector chosen to express El A. In CHO cells using SV40 promoters to express El A genes, the frequency of obtaining cell lines expressing appropriate levels of activator is about 1/12 (2 out of 24 clones screened).
The cell line CHO-L761h has been shown to be a useful new host cell line both for transient expression and for the generation of permanent cell lines. Expression of procollagenase in CHOL761h led to greater than 10-fold higher levels of product secretion than from CHO-K1 cells. Although the expression levels are not as high as those obtained when expressing TIMP, the productivity attainable will depend on the protein expressed. CHO-L761h has also been used to express a number of other proteins efficiently, including recombinant antibodies (C. Gofton unpublished), indicating that this system may be generally useful for the expression of cloned genes in CHO cells.
